Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2012
12/27/2012US20120328609 Modulation of Axon Degeneration
12/27/2012US20120328608 Methods of treating cancer using notch antagonists
12/27/2012US20120328607 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
12/27/2012US20120328606 Methods Of Diagnosing And Treating Pulmonary Diseases Or Disorders
12/27/2012US20120328605 Compositions and uses
12/27/2012US20120328604 Methods and compositions for treating and preventing disease associated with avb5 integrin
12/27/2012US20120328603 Assays and methods using biomarkers
12/27/2012US20120328602 Compositions and methods for treating conditions associated with ceramide biosynthesis
12/27/2012US20120328601 Modulation of Synaptic Maintenance
12/27/2012US20120328600 Injection of fibrin sealant using reconstituted components in spinal applications
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328564 Camptothecin-Binding Moiety Conjugates
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328562 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients
12/27/2012US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease
12/27/2012US20120328558 Antibody-light fusion products for cancer therapeutics
12/27/2012US20120328526 Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
12/27/2012US20120328524 Anti-gd2 antibodies and methods and uses related thereto
12/27/2012US20120328513 Compositions against cancer antigen liv-1 and uses thereof
12/27/2012US20120328511 Novel Antigen Binding Proteins
12/27/2012CA2875484A1 Influenza virus mutants and uses therefor
12/27/2012CA2840461A1 Anti-erbb3 antibody
12/27/2012CA2840270A1 Methods of treating chronic disorders with complement inhibitors
12/27/2012CA2840170A1 Focused radiation for augmenting immune-based therapies against neoplasms
12/27/2012CA2840113A1 An il-15 and il-15r.alpha. sushi domain based immunocytokines
12/27/2012CA2839811A1 Materials and methods for modulating immune responses
12/27/2012CA2839563A1 Anti-alpha synuclein binding molecules
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839508A1 Anti-axl antibodies and uses thereof
12/27/2012CA2839480A1 Anti-axl antibodies and uses thereof
12/27/2012CA2837651A1 Compositions and methods for the therapy and diagnosis of cancer
12/27/2012CA2834618A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
12/26/2012EP2537933A1 An IL-15 and IL-15Ralpha sushi domain based immunocytokines
12/26/2012EP2537932A1 Compositions for and methods of identifying antigens
12/26/2012EP2537931A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide
12/26/2012EP2537857A2 Mutant forms of streptolysin O
12/26/2012EP2537530A1 Radiation therapy agent
12/26/2012EP2537529A1 Lox and loxl2 inhibitors antibodies and uses thereof
12/26/2012EP2537416A1 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
12/26/2012EP2537030A1 A pharmaceutical composition of killed cells with substantially retained immunogenicity
12/26/2012EP2536838A2 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
12/26/2012EP2536836A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536835A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536834A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536833A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536830A1 Polypeptides
12/26/2012EP2536763A1 Activatable constructs
12/26/2012EP2536762A2 INTEGRIN alpha V beta 8 NEUTRALIZING ANTIBODY
12/26/2012EP2536761A2 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
12/26/2012EP2536760A2 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
12/26/2012EP2536759A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536748A1 Neuregulin antagonists and use thereof in treating cancer
12/26/2012EP2536468A1 Treatment of chronic inflammatory conditions
12/26/2012EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
12/26/2012EP2536432A1 Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
12/26/2012EP2536431A2 Compositions and methods for inhibiting mmset
12/26/2012EP2536430A1 Compositions and methods for targeting type 1 interferon producing cells
12/26/2012EP2536429A2 Peptides for vaccines against birch allergy
12/26/2012EP2536428A1 Universal virus-like particle (vlp) influenza vaccines
12/26/2012EP2536427A1 Ic31 nanoparticles
12/26/2012CN1965086B Polyvalent viral vectors and a system for production thereof
12/26/2012CN102844661A Biomarkers of gastric cancer and use thereof
12/26/2012CN102844443A Methods and compositions for the diagnosis and treatment of thyroid cancer
12/26/2012CN102844442A Methods for identifying and isolating cells expressing a polypeptide
12/26/2012CN102844330A Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
12/26/2012CN102844050A Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
12/26/2012CN102844049A Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor
12/26/2012CN102844048A Pharmaceutical agent for treatment and/or prevention of cancer
12/26/2012CN102844047A Immunogenic compositions including tlr activity modulators
12/26/2012CN102844046A Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof
12/26/2012CN102844045A Antibody drug conjugates (adc) that bind to 161p2f10b proteins
12/26/2012CN102844033A Methods and compositions for improving implant osseointegration
12/26/2012CN102839183A Preparation method and application of recombinant enterovirus 71 type virus-like particle
12/26/2012CN102839160A Recombination influenza virus of high-efficiency expression HA (Hyaluronic Acid) protein, as well as preparation method and application thereof
12/26/2012CN102839159A CoxA16 virus strain and human CoxA16 inactivated vaccine
12/26/2012CN102839158A Canine distemper attenuated vaccine strain and medical purpose
12/26/2012CN102839157A MDCK cell system capable of stably coexpressing Hst3GIIV and beta1-4GalT1 and establishing method and application thereof
12/26/2012CN102838680A Helicobacter pylori multiple-epitope fusion protein and multiple-epitope vaccine prepared by helicobacter pylori multiple-epitope fusion protein
12/26/2012CN102838679A Preparation and application of Her2-neu antigen positive tumor therapeutic vaccine
12/26/2012CN102838675A Ip-10 antibodies and their uses
12/26/2012CN102838673A Methods of modifying antibodies and modified antibodies with improved functional properties
12/26/2012CN102838668A Plasmodium falciparum pfs25 protein dipolymer derivative and application thereof
12/26/2012CN102838659A Plasmodium vivax antigen polypeptide, IgY antibody, and application thereof in malaria diagnosis
12/26/2012CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease
12/26/2012CN102836438A Multi-component biological transport systems
12/26/2012CN102836431A Method for preparing inactivated vaccine of anti-Listonella-anguillarum egg yolk antibody
12/26/2012CN102836430A Application of blocking antibody T5E3 to reversing of tumor multidrug resistance
12/26/2012CN102836429A Antibody-based targeting medicine used for repairing damaged tissues, administration method, and magnetic resonance imaging contrast agent
12/26/2012CN102836428A Inactivated vaccine preparation method for egg yolk antibody for resisting litopenaeus vannamei red body disease
12/26/2012CN102836427A Duck virus hepatitis (DVH) immunostimulating complex (ISCOM) and preparation method thereof
12/26/2012CN102836426A Novel immunogenic composition for prevention and treatment of meningococcal disease
12/26/2012CN102836425A A tuberculosis vaccine comprising antigens expressed during a latent infection phase
12/26/2012CN102836424A Vaccine for preventing and treating scars and preparation method thereof
12/26/2012CN102836423A Separation method for nucleic acid and application thereof
12/26/2012CN102327623B Preparation method of DNA (deoxyribonucleic acid) vaccine nanoparticles containing PLGA (Poly-lactide-co-glycolide) for ND (necastle disease)
12/26/2012CN102304496B Attenuated culture of high-pathogenic porcine reproductive and respiratory syndrome virus attenuated vaccine GDr strain
12/26/2012CN102242083B 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I
12/26/2012CN102205120B Production method of porcine parvovirus inactivated vaccine
12/26/2012CN102168088B T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine
12/26/2012CN102161982B Monoclonal antibodies (McAb) against human CXCR3 molecules and application thereof
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 1823